Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Textile factory fire in southern Chinese city of Foshan kills 8
At least 3 killed in Pakistani airstrike on Afghanistan
Typhoon approaches eastern Japan, prompts flood and landslide warnings
Australia to seek UN Security Council seat from 2029
